lenalidomide has been researched along with ks370g in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (ks370g) | Trials (ks370g) | Recent Studies (post-2010) (ks370g) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 18 | 0 | 13 |
| Protein | Taxonomy | lenalidomide (IC50) | ks370g (IC50) |
|---|---|---|---|
| Interstitial collagenase | Homo sapiens (human) | 3.3013 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.0082 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0073 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hogan, L; Kim, MJ; Lassalle-Claux, G; Luiker, K; Murugesan, A; Reiman, T; Selka, A; Touaibia, M; Vaillancourt, E | 1 |
1 other study(ies) available for lenalidomide and ks370g
| Article | Year |
|---|---|
Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.
Topics: Angiogenesis Inhibitors; Apoptosis; Caffeic Acids; Cell Line, Tumor; Down-Regulation; Genes, myc; Humans; Ikaros Transcription Factor; Interferon Regulatory Factors; Lenalidomide; Multiple Myeloma; Phenylethyl Alcohol; Sp1 Transcription Factor; Structure-Activity Relationship | 2020 |